Lion Point Capital’s Ventyx Biosciences VTYX Stock Holding History

Lion Point Capital’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-41,500	Closed	-$375K	–	39
2025 Q4	$375K	Buy	+41,500	New	+$310K	1.94%	23

Other funds holding VTYX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Lion Point Capital's VTYX Position: Q1 2026 in Review

Lion Point Capital sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 41,500 shares — an estimated $375K sold.

Lion Point Capital first reported a position in VTYX in Q4 2025 and held it in 1 quarter. The position peaked at $375K in Q4 2025. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

Lion Point Capital reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
Lion Point Capital sold 41,500 Ventyx Biosciences shares in Q1 2026, an estimated $375K.
Lion Point Capital first reported a position in Ventyx Biosciences in Q4 2025 and held it in 1 quarter.
Lion Point Capital's Ventyx Biosciences position peaked at $375K in Q4 2025.
1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on Lion Point Capital's 13F filing for Q1 2026, filed 15 May 2026.